Biotechnology News

Allogenetics Appoints Dr. Olaf Schermeier as Chairman of the Advisory Board

Atrogi announces positive human data for ATR-258, its first-in-class, oral therapy designed to improve muscle function and body composition

DaltonTx, the decision engine for drug discovery, launches advanced AI-powered antibody discovery platform

- La publicación en esta prestigiosa revista, tras un riguroso proceso de revisión por parte de otros expertos del sector, avala el estudio VIRAGE y respalda la evaluación continuada de VCN-01 en el...

东京, Oct. 01, 2026 (GLOBE NEWSWIRE) -- 日本 Omotesando Helene Clinic与韩国 Maison Privé Clinic 已签署合作备忘录（MOU），旨在促进两国之间的医疗交流，并进一步完善海外患者的就医支持体系。 根据本次协议，双方将在多个领域展开合作，包括再生医疗等医疗领域的信息交流、医疗人员交流、患者就诊前后的支持，以及 VVIP...

NEW YORK, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”), a clinical stage biotechnology company focused on developing...

LOS ANGELES, CA, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “we” or “us” or “IMMX”), a global leader in relapsed/refractory AL Amyloidosis, today announced the...

WARREN, N.J., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Tevogen Inc. (“Tevogen” or the “Company”) (Nasdaq: TVGN), an integrated healthcare enterprise combining biotechnology, artificial intelligence, and...

Leader in targeted immuno-oncology drug development brings three decades of academic and biopharmaceutical oncology expertise SOUTH SAN FRANCISCO, Calif., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Pliant...

Longeveron (LGVN) to participate in three upcoming Longevity/Aging investment conferences.